• Home
  • Transcript levels of androgen receptor variant AR-V1 or AR-V7 do not predict recurrence in patients with prostate cancer at indeterminate risk for progression.

Transcript levels of androgen receptor variant AR-V1 or AR-V7 do not predict recurrence in patients with prostate cancer at indeterminate risk for progression.

Author List
Zhao H, Coram MA, Nolley R, Reese SW, Young SR, Peehl DM
Publication
The Journal of urology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1165783
Publication Year
2012
PubMed ID
23088973
Publication Title
Zhao H, Coram MA, Nolley R, Reese SW, Young SR, Peehl DM. Transcript levels of androgen receptor variant AR-V1 or AR-V7 do not predict recurrence in patients with prostate cancer at indeterminate risk for progression. J Urol. 2012 Dec; 188(6):2158-64.